The third installment of the UP webinar series, “Stop COVID Deaths: Clinical Management Updates,” will happen on Friday, May 8, at 12:00 PM in Taipei.
Dr. Marissa Alejandria will talk about “The Treatment Landscape of COVID-19.”
She is the director of the Institute of Clinical Epidemiology of the National Institutes of Health, UP Manila (UPM); a professor at the UPM College of Medicine (UPCM); and the president of the Philippine Society for Microbiology and Infectious Diseases.
Dr. Alejandria leads the Philippine contingent participating in “Solidarity,” the international randomized and adaptive clinical trial to test the safety and effectiveness of four possible therapies in treating COVID-19 in comparison to standard of care.
“Solidarity” involves more than 100 countries around the world. The Philippines has 20 hospitals participating in the study that investigates the safety and potential therapeutic effects of the following: the investigational antiviral Remdesivir, antimalarial drug Chloroquine or Hydroxychloroquine, antiretroviral drugs used to treat HIV Lopinavir with Ritonavir, and Lopinavir with Ritonavir plus Interferon beta-1a.
“Stop COVID Deaths” was launched on April 24 with “Clinical Management of COVID-19 Pneumonia.” The speakers were Dr. Camilo Roa, Global Governor of the American College of Chest Physicians; Dr. Aileen David Wang of the UPCM’s Department of Medicine; and Dr. Leonora Fernandez, head of the UP-Philippine General Hospital (PGH) Division of Pulmonary Medicine.
The second episode, “Fighting Back COVID-19 Infection,” was held on May 1 and featured Dr. Regina P. Berba, head of the UP-PGH Infection Control Unit and a member of the UPCM faculty, and Dr. Marie Yvette Barez, chair of the Infection Prevention and Control Unit of the Southern Philippines Medical Center.
The UP webinar series taps into the experiences of clinicians, hospital administrators, and researchers with the goal of protecting the health systems against COVID-19 by bridging the gap between knowledge and practice in the clinical management of cases in the Philippines.
The University has partnered with the National Telehealth Center and the Philippine Health Insurance Corporation for this undertaking. These institutions are united in its support for the promotion of the highest possible standards of care for COVID-19 patients. They endeavor to protect the entire health system from the devastation of viral spread through measures and interventions that will insulate the whole range of the practice of medicine and all its sub-specialties in the post-enhanced community quarantine phase and for continued pandemic preparedness and response.
To register for the webinar series, click the link: http://bit.ly/StopCOVIDDeathsWebinar3.
